Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)

DUSA Pharmaceuticals

Programmatic AI Search & Model Visibility Audit

Share of Model (SOM)
15.0%
+2.5% 30-Day Momentum
🧠 Neural Valency:Neutral

Algorithmic Threat Detection

Primary Competitor Threat
Galderma
Competitor Displacement Rate
10.0%

Competitors are displacing DUSA Pharmaceuticals in 10.0% of high-intent buyer queries.

Algorithmic Rationale: Competitors have stronger brand recognition and broader dermatological treatment offerings.
Missing AI Citations:
[aad.org][skintreatmentguide.com]
⚠️ Identified Vulnerability:Brand Recognition
Primary Threat Identified:Galderma
Target Persona:Dermatologists
🚨 Threat Velocity:4/10
Unlock Full Threat Report (30 Free Credits)